Mathai Mammen - Insider Trading & Ownership

Entity
Individual
Location
Theravance,Inc., 901 Gateway Blvd., South San Francisco, CA
Summary
The estimated net worth of Mathai Mammen is at least $15.1M dollars as of June 13, 2024. Mathai Mammen is the EVP, Pharm, R&D of JOHNSON & JOHNSON and owns shares of JOHNSON & JOHNSON (JNJ) stock worth about $10.8M. Mathai Mammen is the Director of 10x Genomics, Inc. and owns shares of 10x Genomics, Inc. (TXG) stock worth about $4.38M.
All Insider Reports
All Insider Reports

Ownership of Mathai Mammen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JNJ JOHNSON & JOHNSON EVP, Pharm, R&D $10.8M Feb 14, 2022
TXG 10x Genomics, Inc. Director $4.38M Jun 11, 2024

Insider Transactions Reported by Mathai Mammen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.